These results suggested that Baicalein inhibits cell growth and induced differentiation accompanied with an increase of C/EBPα‐p42/ C/EBPα‐p30 ratio in AML cell lines and primary AML cells. Here, CEBPA is linked to acute myeloid leukemia.